Inventiva SA header image

Inventiva SA

IVA

Equity

ISIN FR0013233012 / Valor 35598121

Euronext - Euronext Paris (2026-09-18)
EUR 3.23-2.56%

Inventiva SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Inventiva SA is a clinical-stage biopharmaceutical company based in France, publicly traded on Euronext, that discovers and develops oral small-molecule therapies aimed primarily at liver, fibrotic and metabolic diseases and certain rare genetic disorders. Its most advanced program is lanifibranor (IVA337), a pan-PPAR agonist being developed as a treatment for non-alcoholic steatohepatitis (NASH), and the company also pursues drug candidates for lysosomal storage and muscle-related conditions. Inventiva advances compounds through preclinical and clinical studies and seeks collaborations and licensing arrangements to support development and potential commercialization.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-28.1%1Y
-14.0%3Y
-72.3%5Y

Performance

62.4%1Y
61.7%3Y
62.8%5Y

Volatility

Market cap

771 M

Market cap (USD)

Daily traded volume (Shares)

714,530

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%EUR 71.60
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.55%USD 76.78
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.44%USD 23.35
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.09%USD 269.99
HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%USD 95.14
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.11%USD 43.39
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.04%USD 19.72
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.50%EUR 19.88
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.94%USD 44.44
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 531.52